Ultrastructural Myocardial Reorganization during Experimental Treatment with Doxorubicin and Atorvastatin.

Yuzhik, E I; Klinnikova, M G; Koldysheva, E V; Kapustina, V I; Lushnikova, E L

Yuzhik, E I; Klinnikova, M G; Koldysheva, E V; Kapustina, V I; Lushnikova, E L.

Afiliación

Yuzhik EI; Federal Research Center of Fundamental and Translational Medicine, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia. pathol@inbox.ru.
Klinnikova MG; Federal Research Center of Fundamental and Translational Medicine, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia.
Koldysheva EV; Federal Research Center of Fundamental and Translational Medicine, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia.
Kapustina VI; Federal Research Center of Fundamental and Translational Medicine, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia.
Lushnikova EL; Federal Research Center of Fundamental and Translational Medicine, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia.

Bull Exp Biol Med ; 174(1): 109-115, 2022 Nov.

Article en En | MEDLINE | ID: mdl-36437329

Asunto(s)

Doxorrubicina; Ratas; Animales; Atorvastatina/farmacología; Ratas Wistar; Doxorrubicina/farmacología

Palabras clave

atorvastatin; doxorubicin; morphometry; myocardium; ultrastructure

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Doxorrubicina Límite: Animals Idioma: En Revista: Bull Exp Biol Med Año: 2022 Tipo del documento: Article País de afiliación: Rusia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google